StonvexLoading…
StonvexStonvexStonvexCore line items from ELSE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.58M | $10.14M | $7.39M | $4.64M |
Operating Income | $-218.00K | $2.00K | $10.00K | $-171.00K |
Net Income | $-116.00K | $306.00K | $203.00K | $-5.00K |
EPS (Diluted) | $-0.03 | $0.09 | $0.06 | $0.00 |
Total Assets | $16.06M | $15.70M | $15.74M | $15.16M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $10.76M | $10.54M | $10.57M | $10.18M |
Free Cash Flow OCF − CapEx | $40.00K | $597.00K | $623.00K | $234.00K |
Shares Outstanding | 3.53M | 3.48M | 3.48M | 3.45M |